A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
This study will evaluate the safety, tolerability, efficacy and pharmacokinetics of aripiprazole intramuscular (IM) depot multiple doses every 4 weeks in adult patients with schizophrenia.
Epistemonikos ID: e44940c052e45d141d5e78c8825de2008246b3b9
First added on: May 11, 2024